References

1. Talari SA, Talaei R, Shajari GR, Vakili Z, Taghaviardakani A, 2006. Childhood cutaneous leishmaniasis: report of 117 cases from Iran. Korean J Parasitol 44 : 355–360.
   [Google Scholar]
2. Hepburn NC, 2000. Cutaneous leishmaniasis. Clin Exp Dermatol 25 : 363–370.
   [Google Scholar]
3. Khatami A, Firooz A, Gorouhi F, Dowlati Y, 2007. Treatment of acute Old World cutaneous leishmaniasis: a systematic review of the randomized controlled trials. J Am Acad Dermatol 57 : 335.
   [Google Scholar]
4. Palacios R, Osorio LE, Grajales LF, Ochoa MT, 2001. Treatment failure in children in a randomized clinical trial with 10 and 20 days of meglumine antimonite for cutaneous leishmaniasis due to Leishmania Viannia species. Am J Trop Med Hyg 64 : 187–193.
   [Google Scholar]
5. Cruz A, Rainey PM, Herwaldt BL, Stagni G, Palacios R, Trujillo R, Saravia NG, 2007. Pharmacokinetics of antimony in children treated for leishmaniasis with meglumine antimoniate. J Infect Dis 195 : 602–608.
   [Google Scholar]
6. Sharifi I, Fekri AR, Aflattonian MR, Nadim A, Nikian Y, Kamesipour A, 1998. Cutaneous leishmaniasis in primary school children in the south-eastern Iranian city of Bam, 1994–95. Bull World Health Organ 76 : 289–293.
   [Google Scholar]
7. Stavropoulos PG, Papakonstantinou AM, Petropoulou H, Kontochristopoulos G, Katsambas A, 2006. Cryotherapy as an adjunct to systemic antimonials for cutaneous leishmaniasis in children. J Eur Acad Dermatol Venereol 20 : 765–766.
   [Google Scholar]
8. Minodier P, Noël G, Blanc P, Uters M, Retornaz K, Garnier JM, 2005. Management of cutaneous leishmaniasis in adults and children. Med Trop 65 : 487–495.
   [Google Scholar]
9. Kafetzis DA, 2003. An overview p of paediatric leishmaniasis. J Postgrad Med 49 : 31–38.
   [Google Scholar]
10. Dowlati Y, 1996. Cutaneous leishmaniasis: clinical aspect. Clin Dermatol 14 : 425–431.
    [Google Scholar]
11. Hadighi R, Mohebali M, Boucher P, Hajjaran H, Khamesipour A, Quellette M, 2006. Unresponsiveness to glucantime treatment in Iranian cutaneous leishmaniasis due to drug-resistant Leishmania tropica parasites. PLoS Med 3 : 0659–0667.
    [Google Scholar]
12. Leibovici V, Homayoun A, 1986. Cryotherapy in acute cutaneous leishmaniasis. Int J Dermatol 25 : 473–475.
    [Google Scholar]
13. Mosleh IM, Geith E, Natshen L, Schonian G, Abotteen N, Kharabsheh S, 2008. Efficacy of a weekly cryotherapy regimen to treat Leishmania major cutaneous leishmaniasis. J Am Acad Dermatol 58 : 617–624.
    [Google Scholar]
14. Asilian A, Sadeghinia A, Faghihi G, Momeni A, Amini Harandi A, 2003. The efficacy of treatment with intralesional meglumine antimoniate alone, compared with that of cryotherapy combined with the meglumine antimoniate or intralesional sodium stibogluconate, in the treatment of cutaneous leishmaniasis. Ann Trop Med Parasitol 97 : 493–498.
    [Google Scholar]
15. Gurei MS, Tatli N, Ozbilge H, Erel O, Seyrek A, Kocyigit A, Ulukanligil M, 2000. Efficacy of crotherapy and intralesional Pentostam in treatment of cutaneous leishmaniasis. J Egypt Soc Parasitol 30 : 169–176.
    [Google Scholar]
16. Leibovici V, Aram H, 1986. Cryotherapy in acute cutaneous leishmaniasis. Int J Dermatol 25 : 473–475.
    [Google Scholar]